What is Seed?
Seed develops, manufactures, and sells probiotic bacteria supplements for consumers, operating from its headquarters in Venice, California. The company targets the growing market for gut health and wellness products, leveraging scientific research to formulate its offerings. Its business model centers on providing high-quality, evidence-based probiotic solutions to a health-conscious consumer base, positioning itself as a key player in the functional food and supplement industry.
How much funding has Seed raised?
Seed has raised a total of $40M across 1 funding round:
Series A
$40M
Series A (2021): $40M with participation from ARTIS Ventures, GISEV, Founders Fund, 8VC, and The Craftory
Key Investors in Seed
ARTIS Ventures
ARTIS Ventures is a venture capital firm specializing in Tech Bio+Health, focusing on data-driven life sciences companies that aim to improve human health. They invest in scalable medical technologies, personalized therapeutics, and drug discovery solutions, promoting an engineering-first approach to create lasting health impacts.
Founders Fund
Founders Fund is a venture capital firm that invests in significant companies across all sectors and stages. Known for its founder-friendly approach, the firm has backed numerous successful technology companies and provides substantial support to its portfolio companies.
8VC
8VC is a technology investment firm that backs visionary teams and industry-transforming companies. With a focus on smart enterprise platforms across various sectors including healthcare and Bio-IT, the firm leverages its partners' experience as founders and operators to support portfolio growth.
What's next for Seed?
The recent major strategic investment signals Seed's intent to accelerate its growth and potentially expand its product lines or enter new markets. With substantial backing, the company is likely to focus on enhancing its manufacturing capabilities, increasing its marketing and distribution efforts, and further investing in research and development to maintain its competitive edge. This funding will be critical for solidifying its position as a leader in the probiotic supplement market and capitalizing on the increasing consumer demand for scientifically validated health products.
See full Seed company page
